Acorda Therapeutics reported $-27071000 in Net Income for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Agios Pharmaceuticals AGIO:US $ -94.63M 5.86M
Aptinyx Inc APTX:US $ -19827000 217K
Arrowhead Research ARWR:US $ 44.37M 107.24M
Cytokinetics CYTK:US $ -89.44M 58.88M
Enanta Pharmaceuticals ENTA:US $ -33.59M 3.48M
Novartis NOVN:VX SF 16308M 13550M
Teva Pharmaceutical TEVA:IT -158000000 448M